Exelixis Inc. buy Royal Bank of Canada
Start price
14.05.25
/
50%
€39.53
Target price
14.05.26
€35.75
Performance (%)
-10.42%
Price
16.12.25
€35.41
Summary
This prediction is currently active. The prediction for Exelixis Inc. disappoints with a performance of -10.42%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | -1.666% | -1.666% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat